Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies

N. Allen; R. Peto; V. Beral; S.W. Kan; G. Reeves; S. Sweetland; R Stevens; T.O. Yang; the Collaborative Group on Epidemiological Studies on Endometrial Cancer; P.A. van den Brandt; L.J. Schouten

doi:10.1016/S1470-2045(15)00212-0

Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies

N. Allen
, R. Peto
, V. Beral
, S.W. Kan
, G. Reeves
, S. Sweetland
, R Stevens
, T.O. Yang
, the Collaborative Group on Epidemiological Studies on Endometrial Cancer
, P.A. van den Brandt
, L.J. Schouten

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Background oral contraceptives are known to reduce the incidence rate of endometrial cancer, but it is uncertain how long this effect lasts after use ceases, or whether it is modified by other factors.

Original language	English
Pages (from-to)	1061-1070
Number of pages	10
Journal	Lancet oncology
Volume	16
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(15)00212-0
Publication status	Published - 1 Jan 2015

Access to Document

10.1016/S1470-2045(15)00212-0

Cite this

Allen, N., Peto, R., Beral, V., Kan, S. W., Reeves, G., Sweetland, S., Stevens, R., Yang, T. O., Collaborative Group on Epidemiological Studies on Endometrial Cancer, T., van den Brandt, P. A., & Schouten, L. J. (2015). Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. Lancet oncology, 16(9), 1061-1070. https://doi.org/10.1016/S1470-2045(15)00212-0

@article{7f952208cc4a43e287ff60f9c100062d,

title = "Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies",

abstract = "Background oral contraceptives are known to reduce the incidence rate of endometrial cancer, but it is uncertain how long this effect lasts after use ceases, or whether it is modified by other factors.",

author = "N. Allen and R. Peto and V. Beral and S.W. Kan and G. Reeves and S. Sweetland and R Stevens and T.O. Yang and \{Collaborative Group on Epidemiological Studies on Endometrial Cancer\}, the and \{van den Brandt\}, P.A. and L.J. Schouten",

year = "2015",

month = jan,

day = "1",

doi = "10.1016/S1470-2045(15)00212-0",

language = "English",

volume = "16",

pages = "1061--1070",

journal = "Lancet oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "9",

}

Allen, N, Peto, R, Beral, V, Kan, SW, Reeves, G, Sweetland, S, Stevens, R, Yang, TO, Collaborative Group on Epidemiological Studies on Endometrial Cancer, T, van den Brandt, PA & Schouten, LJ 2015, 'Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies', Lancet oncology, vol. 16, no. 9, pp. 1061-1070. https://doi.org/10.1016/S1470-2045(15)00212-0

TY - JOUR

T1 - Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies

AU - Allen, N.

AU - Peto, R.

AU - Beral, V.

AU - Kan, S.W.

AU - Reeves, G.

AU - Sweetland, S.

AU - Stevens, R

AU - Yang, T.O.

AU - Collaborative Group on Epidemiological Studies on Endometrial Cancer, the

AU - van den Brandt, P.A.

AU - Schouten, L.J.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background oral contraceptives are known to reduce the incidence rate of endometrial cancer, but it is uncertain how long this effect lasts after use ceases, or whether it is modified by other factors.

AB - Background oral contraceptives are known to reduce the incidence rate of endometrial cancer, but it is uncertain how long this effect lasts after use ceases, or whether it is modified by other factors.

U2 - 10.1016/S1470-2045(15)00212-0

DO - 10.1016/S1470-2045(15)00212-0

M3 - Article

SN - 1470-2045

VL - 16

SP - 1061

EP - 1070

JO - Lancet oncology

JF - Lancet oncology

IS - 9

ER -

Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies

Abstract

Access to Document

Fingerprint

Cite this